These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17242633)

  • 1. Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women.
    Di Carlo C; Tommaselli GA; Di Spiezio Sardo A; Sammartino A; Attianese W; Gargano V; Bifulco G; Nappi C
    Menopause; 2007; 14(3 Pt 1):450-4. PubMed ID: 17242633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
    Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.
    Ting GP; Tan SY; Chan SP; Karuthan C; Zaitun Y; Suriah AR; Chee WS
    J Nutr Health Aging; 2007; 11(1):69-73. PubMed ID: 17315084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.
    Sun A; Lin S; Yu W; Qin M; Chen F; Zhang Y; Wei Y; de Lignieres B
    Chin Med J (Engl); 2002 Dec; 115(12):1790-5. PubMed ID: 12622925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
    Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
    Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
    Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
    Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC; Cosper P; Nakhuda GS; Lobo RA
    Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
    Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
    García-Pérez MA; Moreno-Mercer J; Tarín JJ; Cano A
    Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Mannazzu M; Falchi A; Sanna D; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
    Odabasi AR; Yuksel H; Karul A; Kozaci D; Sezer SD; Onur E
    Saudi Med J; 2007 Jun; 28(6):855-61. PubMed ID: 17530099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.